If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?It has been some time since I last posted about Insulet Corporation ( PODD ) for Seeking Alpha. My last coverage was in November 2024, and I assigned the stock a Hold rating. That seems toEdmund Ingham is a biotech ...

Key Takeaways PODD reported Q4 EPS of $1.55, up 34.8%, as revenues rose 31.2% and beat estimates.Insulet's Omnipod sales climbed 33.5%, with international revenues surging more than 50%.PODD expanded gross and operating margins and guided 20%-22% CER revenue growth for 2026.Insulet Corporation (PODD) reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.55, up 34.8% from the year-ago period’s figure. The bottom line surpassed the Zacks Consensus Estimate by 4.87%.GAAP EPS came in at $1.44, up ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-33462 INSULET CORPORATION (Exact name of Registrant as specified in its charter) Delaware 04-3523891 (State or Other Jurisdict ...

Insulet Corporation (NASDAQ:PODD) stock is trading higher on Wednesday after the company reported better-than-expected fourth-quarter earnings and 2026 guidance.Fourth-quarter adjusted earnings reached $1.55 per share, beating the consensus of $1.45.The automated insulin delivery technology maker reported sales of $783.8 million, up 31.2% year over year or 29% in constant currency (CC), beating the consensus of $768.69 million, exceeding the high end of the company's guidance range of 25% to 28% in constant ...

Insulet said it achieved record new customer starts in the fourth quarter and for the full year across the U.S., international markets, and company-wide. CFO Flavia Pease noted that in the U.S. during the fourth quarter, more than 85% of new customer starts came from people transitioning from multiple daily injections (MDI), and type 2 represented more than 40% of all starts.For the full year, the company reported revenue of more than $2.7 billion , up 29.5% constant currency (30.7% reported). Management sa ...

Insulet (PODD) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.87%. A quarter ago, it was expected that this maker of insulin infusion systems would post earnings of $1.13 per share when it actually produced earnings of $1.24, delivering a surprise of +9.73%.Over the last four quar ...

Insulet (NasdaqGS:PODD) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Company ParticipantsAshley McEvoy - President and CEOClare Trachtman - VP of Investor RelationsEric Benjamin - COOFlavia Pease - CFOJoanne Wuensch - Managing DirectorConference Call ParticipantsDanielle Antalffy - Managing Director and Senior Equity Research AnalystDavid Roman - Managing Director and Senior AnalystJeff Johnson - Managing Director and Senior Research AnalystLarry Biegelsen - Managing Director and Senior AnalystMichae ...

Insulet (NasdaqGS:PODD) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Company ParticipantsAshley McEvoy - President and CEOClare Trachtman - VP of Investor RelationsEric Benjamin - COOFlavia Pease - CFOJoanne Wuensch - Managing DirectorConference Call ParticipantsDanielle Antalffy - Managing Director and Senior Equity Research AnalystDavid Roman - Managing Director and Senior AnalystJeff Johnson - Managing Director and Senior Research AnalystLarry Biegelsen - Managing Director and Senior AnalystMichae ...

Insulet (NasdaqGS:PODD) Q4 2025 Earnings call February 18, 2026 08:00 AM ET Speaker9Good morning, and welcome to the Insulet Corporation fourth quarter and full year 2025 earnings call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Clare Trachtman, Vice President, Investor Relations.Speaker1Good morning, and welcome to our fourth quarter and full year 2025 earnings call. Joining me today are Ashley McEvoy, President and Chief Executive Offi ...

The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM and Controller are not waterproof. Safe Harbor Statement This presentation contains forward-looking statements regarding, among other things, future operating and financial performance, product success and efficacy, the outcome of studies and trials, and the approval of products by regulatory bodies. These forward-looking statements are based on management's current beliefs, assumptions, and estimates and are not intended to be a guarantee ...